UBC-developed formulation of leishmaniasis drug shown to be stable and effective in tropical temperatures
A new formulation of Amphotericin B (AmB) developed by University of British Columbia researchers has been shown to be stable in tropical climates and effective in treating Visceral Leishmaniasis (VL) in mouse models.
Dec 7, 2010